These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24801013)

  • 1. The evolving dynamics of the microbial community in the cystic fibrosis lung.
    McGuigan L; Callaghan M
    Environ Microbiol; 2015 Jan; 17(1):16-28. PubMed ID: 24801013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microevolution of Pseudomonas aeruginosa to a chronic pathogen of the cystic fibrosis lung.
    Hogardt M; Heesemann J
    Curr Top Microbiol Immunol; 2013; 358():91-118. PubMed ID: 22311171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of multispecies social interactions in shaping Pseudomonas aeruginosa pathogenicity in the cystic fibrosis lung.
    O'Brien S; Fothergill JL
    FEMS Microbiol Lett; 2017 Aug; 364(15):. PubMed ID: 28859314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Microbiome in Cystic Fibrosis.
    Huang YJ; LiPuma JJ
    Clin Chest Med; 2016 Mar; 37(1):59-67. PubMed ID: 26857768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Same Game, Different Players: Emerging Pathogens of the CF Lung.
    Gannon AD; Darch SE
    mBio; 2021 Jan; 12(1):. PubMed ID: 33436426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of quorum sensing in chronic cystic fibrosis Pseudomonas aeruginosa infections.
    Winstanley C; Fothergill JL
    FEMS Microbiol Lett; 2009 Jan; 290(1):1-9. PubMed ID: 19016870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staphylococcus aureus in cystic fibrosis: pivotal role or bit part actor?
    Hurley MN; Smyth AR
    Curr Opin Pulm Med; 2018 Nov; 24(6):586-591. PubMed ID: 30113336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystic fibrosis lung environment and Pseudomonas aeruginosa infection.
    Bhagirath AY; Li Y; Somayajula D; Dadashi M; Badr S; Duan K
    BMC Pulm Med; 2016 Dec; 16(1):174. PubMed ID: 27919253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic but not intermittent infection with
    Boutin S; Graeber SY; Stahl M; Dittrich AS; Mall MA; Dalpke AH
    Eur Respir J; 2017 Oct; 50(4):. PubMed ID: 28982777
    [No Abstract]   [Full Text] [Related]  

  • 10. The Evolving Cystic Fibrosis Microbiome: A Comparative Cohort Study Spanning 16 Years.
    Acosta N; Whelan FJ; Somayaji R; Poonja A; Surette MG; Rabin HR; Parkins MD
    Ann Am Thorac Soc; 2017 Aug; 14(8):1288-1297. PubMed ID: 28541746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Microbial Endocrinology of Pseudomonas aeruginosa: Inflammatory and Immune Perspectives.
    Yong VFL; Soh MM; Jaggi TK; Mac Aogáin M; Chotirmall SH
    Arch Immunol Ther Exp (Warsz); 2018 Oct; 66(5):329-339. PubMed ID: 29541797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline.
    Bacci G; Paganin P; Lopez L; Vanni C; Dalmastri C; Cantale C; Daddiego L; Perrotta G; Dolce D; Morelli P; Tuccio V; De Alessandri A; Fiscarelli EV; Taccetti G; Lucidi V; Bevivino A; Mengoni A
    PLoS One; 2016; 11(6):e0156807. PubMed ID: 27355625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial ecology and adaptation in cystic fibrosis airways.
    Yang L; Jelsbak L; Molin S
    Environ Microbiol; 2011 Jul; 13(7):1682-9. PubMed ID: 21429065
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Jurado-Martín I; Sainz-Mejías M; McClean S
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803907
    [No Abstract]   [Full Text] [Related]  

  • 15. A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients.
    Sibley CD; Parkins MD; Rabin HR; Duan K; Norgaard JC; Surette MG
    Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15070-5. PubMed ID: 18812504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Building the microbiome in health and disease: niche construction and social conflict in bacteria.
    McNally L; Brown SP
    Philos Trans R Soc Lond B Biol Sci; 2015 Aug; 370(1675):. PubMed ID: 26150664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential adaptation of microbial pathogens to airways of patients with cystic fibrosis and chronic obstructive pulmonary disease.
    Döring G; Parameswaran IG; Murphy TF
    FEMS Microbiol Rev; 2011 Jan; 35(1):124-46. PubMed ID: 20584083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of bacterial colonisation in the respiratory tract of patients with cystic fibrosis.
    Renders N; Verbrugh H; Van Belkum A
    Infect Genet Evol; 2001 Jul; 1(1):29-39. PubMed ID: 12798048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung.
    Hogardt M; Heesemann J
    Int J Med Microbiol; 2010 Dec; 300(8):557-62. PubMed ID: 20943439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.
    Price KE; Naimie AA; Griffin EF; Bay C; O'Toole GA
    J Bacteriol; 2016 Jan; 198(2):237-47. PubMed ID: 26483523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.